Cargando…

P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Dargel, C, Bassani-Sternberg, M, Krebs, K, Wilde, S, Schendel, D, Busch, DH, Mann, M, Protzer, U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072158/
http://dx.doi.org/10.1186/2051-1426-2-S2-P38
_version_ 1782322914936225792
author Dargel, C
Bassani-Sternberg, M
Krebs, K
Wilde, S
Schendel, D
Busch, DH
Mann, M
Protzer, U
author_facet Dargel, C
Bassani-Sternberg, M
Krebs, K
Wilde, S
Schendel, D
Busch, DH
Mann, M
Protzer, U
author_sort Dargel, C
collection PubMed
description
format Online
Article
Text
id pubmed-4072158
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40721582014-06-27 P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma Dargel, C Bassani-Sternberg, M Krebs, K Wilde, S Schendel, D Busch, DH Mann, M Protzer, U J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072158/ http://dx.doi.org/10.1186/2051-1426-2-S2-P38 Text en Copyright © 2014 Dargel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Dargel, C
Bassani-Sternberg, M
Krebs, K
Wilde, S
Schendel, D
Busch, DH
Mann, M
Protzer, U
P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
title P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
title_full P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
title_fullStr P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
title_full_unstemmed P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
title_short P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
title_sort p64. t cell re-direction against glypican-3 for immunotherapy of hepatocellular carcinoma
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072158/
http://dx.doi.org/10.1186/2051-1426-2-S2-P38
work_keys_str_mv AT dargelc p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma
AT bassanisternbergm p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma
AT krebsk p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma
AT wildes p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma
AT schendeld p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma
AT buschdh p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma
AT mannm p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma
AT protzeru p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma